In-depth and tele-depth interviews
In-depth interviews with the physicians, KOLs and payers who decide — recruited by us and moderated by consultants who know the clinical detail.
Every respondent. Personally sourced. Personally screened.
What we can answer
Semi-structured and open-ended, so they go where the answer is rather than where the guide expected. That is how a study surfaces the objection nobody wrote down.
Where the opportunity sits, and what it costs to be wrong.
Market attractiveness · Unmet need · Segment sizing
The factors that move a product from “useful” to “need to have” for the people prescribing it.
Drivers of uptake · Barriers to adoption · Message testing
Where you sit, and what it takes to become standard of care.
Competitive assessment · Positioning · Standard-of-care mapping
How we source respondents
A “take whoever you can get” recruit is how a study reports the wrong opinion confidently. Three tiers, so hard-to-reach specialties get filled rather than substituted.
For pharma and biotech teams
Three engagements, anonymized. The disease area and the specialists are real; the sponsor, the asset and the study are not named.
Oncology Pipeline assessment
The brief
A drug developer had to decide which early- and late-stage oncology assets to advance, and how to shape the trials behind them.
Who we interviewed
Screened for clinical-trial experience, across lung cancer, lymphoma and genitourinary cancers.
What the team took away
A KOL read on each asset’s target product profile against the standard of care and its in-class competitors, rated in the interview.
Hepatology Early R&D strategy
The brief
A pharma R&D team entering a metabolic liver disease wanted what market reports could not give it: the view of the experts running the trials.
Who we interviewed
Hepatologists with trial experience in the disease, in one-to-one interviews and small group discussions.
What the team took away
A landscape of the pipeline, the endpoints that drive approval and reimbursement, and which patients are likely to be treated first.
Thrombosis Asset evaluation
The brief
A team evaluating an early-stage anticoagulant needed to know where it would be used, a decision spread across many specialties.
Who we interviewed
What the team took away
A specialty-by-specialty map of the anticoagulants used today and in which care settings, and how each specialty reacted to the new concept.
More anonymized work on the case studies page.
Are you a healthcare professional? Clinicians who would like to take part in interviews like these can join our advisory panel.
Why clients come back
MD physicians and PhD scientists run the interviews, not junior moderators reading a script.
Recruitment stays with our own team rather than a shared panel.
Oncology, cardiovascular surgery, endocrinology, pulmonology, payers and pharmacy directors.
IDIs and TDIs by phone or video, focus groups, and on-site studies in hospital.
In their words
KOLgroups is a trustworthy partner for our healthcare market research projects. We have partnered with them quite a few times and I count on them for our TDI/IDI needs.
Sanjeev D. Senior Director · Philadelphia, PA They understood the value proposition of our device and were able to get valuable insights for us.
Ryan R. VP of Business Development FAQ
When you need to understand why rather than how many — the reasoning behind a prescribing decision, the objection nobody wrote down, or how a product actually fits a workflow. Surveys measure what you already know to ask about; interviews surface what you did not.
Our own consultants. MD physicians and PhD scientists run the discussions rather than junior moderators reading a script, which is what lets an interview follow a clinically interesting answer instead of moving to the next question.
Both. In-depth and tele-depth interviews by phone or video, focus groups, and on-site ethnographic studies in hospital.
Yes. Every interview is recorded and transcribed.
We work three tiers in order: established KOL relationships, our in-house network of physicians we have recruited before, and a database of over 2 million HCP profiles for rare specialties.
Yes. Interviews are semi-structured and open-ended, and the guide is built around what the study needs to settle rather than programmed as-is.
Areas of expertise
The clinicians, specialists and decision-makers we recruit and field studies to.
General Surgery · Plastic / Reconstructive · Bariatric / Gastric Bypass · Orthopedic / Arthroscopic · Transplant · Neurological · Thoracic / Cardiovascular · Vascular
Anesthesiology · Physical Medicine & Rehab · Pain Medicine
Dermatology · Rheumatology · Gastroenterology · Endocrinology
Primary Practice (PCP) · Pediatrics · Obstetrics/Gynecology · Psychiatry · Nurse Practitioner (NP) · Physician Assistant (PA)
Ophthalmology · Retina Specialist · Glaucoma Specialist · Optometry · Ophthalmic Assistant
Cardiology · Interventional Cardiology · Cardiac Electrophysiology
Allergy / Asthma · Immunology · Pulmonology · Critical / Emergency
Medical Oncology · Hematology · Pediatric · Infusion Nurses
Retail Chain / Specialty · Hospital Pharmacy Directors · Pharmacy Benefit Managers (PBMs) · Payers / Reimbursement · Formulary Managers
Tell us what you need to learn and who you need to hear it from. We will tell you how we would run it.
